Correlation Between GeneFerm Biotechnology and Lotus Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both GeneFerm Biotechnology and Lotus Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneFerm Biotechnology and Lotus Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GeneFerm Biotechnology Co and Lotus Pharmaceutical Co, you can compare the effects of market volatilities on GeneFerm Biotechnology and Lotus Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneFerm Biotechnology with a short position of Lotus Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneFerm Biotechnology and Lotus Pharmaceutical.

Diversification Opportunities for GeneFerm Biotechnology and Lotus Pharmaceutical

0.07

Correlation Coefficient

GeneFerm Biotechnology  Lotus Pharmaceutical

Significant diversification

The 3 months correlation between GeneFerm and Lotus is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding GeneFerm Biotechnology Co and Lotus Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lotus Pharmaceutical and GeneFerm Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneFerm Biotechnology Co are associated (or correlated) with Lotus Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lotus Pharmaceutical has no effect on the direction of GeneFerm Biotechnology i.e., GeneFerm Biotechnology and Lotus Pharmaceutical go up and down completely randomly.

Pair Corralation between GeneFerm Biotechnology and Lotus Pharmaceutical

Assuming the 90 days trading horizon GeneFerm Biotechnology Co is expected to under-perform the Lotus Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, GeneFerm Biotechnology Co is 1.22 times less risky than Lotus Pharmaceutical. The stock trades about -0.01 of its potential returns per unit of risk. The Lotus Pharmaceutical Co is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  26,300  in Lotus Pharmaceutical Co on September 29, 2024 and sell it today you would earn a total of  850.00  from holding Lotus Pharmaceutical Co or generate 3.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

GeneFerm Biotechnology Co  vs.  Lotus Pharmaceutical Co

GeneFerm Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneFerm Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, GeneFerm Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Lotus Pharmaceutical

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Lotus Pharmaceutical Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Lotus Pharmaceutical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with GeneFerm Biotechnology and Lotus Pharmaceutical

The main advantage of trading using opposite GeneFerm Biotechnology and Lotus Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneFerm Biotechnology position performs unexpectedly, Lotus Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lotus Pharmaceutical will offset losses from the drop in Lotus Pharmaceutical's long position.

The idea behind GeneFerm Biotechnology Co and Lotus Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.